Chapter 1: Indications for Pulmonary Function Testing Test
Test Bank for Ruppel’s Manual of Pulmonary Function Bank
Testing 12th Edition, By Mottram
MULTIPLE CHOICE
Chapter 1 - 13 Updated
1. Who first popularized spirometry for the evaluation of pulmonary function?
a. August and Marie Krogh
b. Alvan Barach
c. John Severinghaus
d. John Hutchinson
ANS: D
Hutchinson popularized the concept of using VC to assess lung function, and the
names he gave to several other lung compartments are still used today.
DIF: 1 REF: p. 2 OBJ: None MSC: NBRC: None
2. Which of the following are indications for performing spirometry?
1. Assess the risk of lung resection.
2. Determine the response to bronchodilator therapy.
3. Assess the severity of restrictive lung disease.
4. Quantify the extent of COPD.
a. 1 and 4
b. 2 and 3
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Spirometry cannot assess severity of restriction; for that you need to measure
lung volumes ( see Box 1-2, Chapter 1).
DIF: 1 REF: p. 7 OBJ: EL-2 MSC: NBRC: None
, Stuvia.com - The Marketplace to Buy and Sell your Study Material
d. Guillain-Barré syndrome
3. The main indication for the measurement of lung volumes is to do which of the
following? ANS: B
a. Diagnose or assess the severity of restriction. Sarcoidosis is the only systemic disease listed that affects gas
b. Evaluate the severity of pulmonary hypertension.
c. Determine the level of cardiopulmonary fitness. exchange. DIF: 1 REF: p. 9 | p. 19 | p. 21 | p. 35 OBJ: EL-2
d. Assess the risk of abdominal surgical procedures.
MSC: NBRC: None
ANS: A
The most common reason for measuring lung volumes is to identify restrictive 5. Blood gas analysis is used with patients with COPD to do
which of the following?
lung disease. DIF: 1 REF: p. 35 OBJ: EL-2 MSC: NBRC: None a. Monitor airway responsiveness.
b. Determine level of cardiopulmonary fitness.
4. DLCO measurements may be indicated to evaluate pulmonary involvement in c. Detect pulmonary hypertension.
which of the following systemic diseases? d. Assess need for supplementary O2.
a. Asthma
b. Sarcoidosis ANS: D
c. Exertional hypoxemia Blood gas analysis is most commonly used to determine the need for
supplemental oxygen and to manage patients who require ventilatory support.
DIF: 2 REF: p. 15 OBJ: EL-
1 MSC: NBRC: CPFT 2A-2
6. Which of the following cause emphysema?
1. 1- Antitrypsin deficiency
2. Exposure to environmental pollutants
3. Radiation therapy
4. Cigarette smoking
a. 1 and 2
b. 3 and 4
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Emphysema is caused primarily by cigarette smoking. Some emphysema is
caused by the absence of a protective enzyme. Chronic exposure to environmental
pollutants can also contribute to the development of emphysema.
DIF: 1 REF: p. 11 OBJ: EL-3 | AL-2 MSC: NBRC: None
7. An adult patient complains of chest tightness and cough whenever he jogs in
cold weather. These symptoms are consistent with which of the following?
a. Cystic fibrosis
b. Asthma
c. Pulmonary hypertension
d. Idiopathic pulmonary fibrosis
|
, ANS: B 11. Which of the following correctly describe(s) appropriate physical
Agents or events that cause an asthmatic episode are called triggers (see Box measurements before pulmonary function testing?
1-7, Chapter 1). Antigens such as animal dander, pollens, and dusts are the 1. Actual body weight should be used to calculate predicted values.
most common triggers. Other common triggers include exposure to air 2. Standing height should be measured when the patient is barefoot.
pollutants and exercise in cold or dry air. 3. Arm span should be used instead of height for a patient with kyphosis.
4. Age should be recorded to the nearest decade (10 years ).
DIF: 2 REF: p. 16 OBJ: EL-3 MSC: NBRC: None
a. 1 only
8. Which of the following statements concerning tumors in the upper airway is true?
b. 2 and 3
a. There may be variable or fixed obstruction.
c. 1 , 2, and 4
b. Fixed obstruction will be present.
d. 1 , 2, 3, and 4
c. Variable obstruction will be present.
d. Small airway obstruction will result. ANS: B
Various physical measurements are required for estimating each patient’s
ANS: A expected level of pulmonary function. Age to the nearest month, height to the
Tumors involving the upper airway may cause variable or fixed obstruction. nearest 0.1 cm, and weight are usually recorded in addition to the patient’s
gender. Race or ethnic origin should also be recorded. (Although body weight is
DIF: 2 REF: p. 19 OBJ: EL- recorded, it is not used to calculate predicted values.)
2 MSC: NBRC: CPFT 3C-3
DIF: 1 REF: p. 29 OBJ:
9. Sarcoidosis is a systemic disorder that usually causes which of the following? None MSC: NBRC: CPFT 3A-
a. A restrictive ventilatory defect 20
b. An obstructive ventilatory defect
c. Hyperreactive airways 12. In addition to explaining the procedure for each pulmonary function test to
d. Primary pulmonary hypertension the patient, the pulmonary function technologist should do which of the
following?
ANS: A a. Briefly explain the physiologic basis of the test.
Restriction is often associated with the following: interstitial lung diseases, b. Demonstrate the correct performance of the test maneuver.
including idiopathic fibrosis, pneumoconioses, and sarcoidosis. c. Limit feedback to the patient to reduce the placebo effect.
d. Explain the exact number of efforts that will be required for each test.
DIF: 1 REF: p. 19 | p. 21 OBJ: EL-3 MSC: NBRC: None
ANS: B
10. For which of the following conditions might pulmonary function testing be In addition to a description of the test, the maneuver should always be
contraindicated? demonstrated.
a. Vocal cord dysfunction
b. Untreated pneumothorax DIF: 1 REF: p. 32 OBJ:
c. Congestive heart failure (CHF) None MSC: NBRC: CPFT 2B-6
d. Bronchiolitis obliterans
13. The single-breath diffusing capacity test was first described by:
ANS: B
a. John Severinghaus
Pulmonary function tests are usually contraindicated in the presence of
b. August and Marie Krogh
pneumothorax. However, undiagnosed pneumothorax may present a risk if
pulmonary function studies are performed. c. Robert Hyatt
d. Leland Clark
DIF: 1 REF: p. 23 OBJ: EL- ANS: B
4 MSC: NBRC: CPFT 2B-6 The basis for the modern single-breath diffusing capacity (DLCO) test was
d. described by August and Marie Krogh in 1911.
DIF: 1 REF: p. 5 OBJ: None MSC: NBRC: None
|
, Stuvia.com - The Marketplace to Buy and Sell your Study Material Stuvia.com - The Marketplace to Buy and Sell your Study Material
14. DLCO measurements may be indicated to evaluate gas exchange abnormality Downloaded by: SuperA |
in which of the following?
Distribution of this document is illegal
a. Ketoacidosis
b. Myasthenia gravis
c. Interstitial lung disease
d. Bronchitis
ANS: C
The other options do not affect the alveolar capillary membrane
interface. DIF: 1 REF: p. 9 OBJ: EL-2 MSC:
NBRC: None
15. Vocal cord dysfunction will typically affect the flow-volume loop in what way?
a. Blunt the expiratory portion of the curve
b. Blunt both the inspiratory and expiratory portions of the curve
c. Blunt the inspiratory portion of the curve
Have no effect on the curve but cause inspiratory stridor
d.
Test Bank for Ruppel’s Manual of Pulmonary Function Bank
Testing 12th Edition, By Mottram
MULTIPLE CHOICE
Chapter 1 - 13 Updated
1. Who first popularized spirometry for the evaluation of pulmonary function?
a. August and Marie Krogh
b. Alvan Barach
c. John Severinghaus
d. John Hutchinson
ANS: D
Hutchinson popularized the concept of using VC to assess lung function, and the
names he gave to several other lung compartments are still used today.
DIF: 1 REF: p. 2 OBJ: None MSC: NBRC: None
2. Which of the following are indications for performing spirometry?
1. Assess the risk of lung resection.
2. Determine the response to bronchodilator therapy.
3. Assess the severity of restrictive lung disease.
4. Quantify the extent of COPD.
a. 1 and 4
b. 2 and 3
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Spirometry cannot assess severity of restriction; for that you need to measure
lung volumes ( see Box 1-2, Chapter 1).
DIF: 1 REF: p. 7 OBJ: EL-2 MSC: NBRC: None
, Stuvia.com - The Marketplace to Buy and Sell your Study Material
d. Guillain-Barré syndrome
3. The main indication for the measurement of lung volumes is to do which of the
following? ANS: B
a. Diagnose or assess the severity of restriction. Sarcoidosis is the only systemic disease listed that affects gas
b. Evaluate the severity of pulmonary hypertension.
c. Determine the level of cardiopulmonary fitness. exchange. DIF: 1 REF: p. 9 | p. 19 | p. 21 | p. 35 OBJ: EL-2
d. Assess the risk of abdominal surgical procedures.
MSC: NBRC: None
ANS: A
The most common reason for measuring lung volumes is to identify restrictive 5. Blood gas analysis is used with patients with COPD to do
which of the following?
lung disease. DIF: 1 REF: p. 35 OBJ: EL-2 MSC: NBRC: None a. Monitor airway responsiveness.
b. Determine level of cardiopulmonary fitness.
4. DLCO measurements may be indicated to evaluate pulmonary involvement in c. Detect pulmonary hypertension.
which of the following systemic diseases? d. Assess need for supplementary O2.
a. Asthma
b. Sarcoidosis ANS: D
c. Exertional hypoxemia Blood gas analysis is most commonly used to determine the need for
supplemental oxygen and to manage patients who require ventilatory support.
DIF: 2 REF: p. 15 OBJ: EL-
1 MSC: NBRC: CPFT 2A-2
6. Which of the following cause emphysema?
1. 1- Antitrypsin deficiency
2. Exposure to environmental pollutants
3. Radiation therapy
4. Cigarette smoking
a. 1 and 2
b. 3 and 4
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Emphysema is caused primarily by cigarette smoking. Some emphysema is
caused by the absence of a protective enzyme. Chronic exposure to environmental
pollutants can also contribute to the development of emphysema.
DIF: 1 REF: p. 11 OBJ: EL-3 | AL-2 MSC: NBRC: None
7. An adult patient complains of chest tightness and cough whenever he jogs in
cold weather. These symptoms are consistent with which of the following?
a. Cystic fibrosis
b. Asthma
c. Pulmonary hypertension
d. Idiopathic pulmonary fibrosis
|
, ANS: B 11. Which of the following correctly describe(s) appropriate physical
Agents or events that cause an asthmatic episode are called triggers (see Box measurements before pulmonary function testing?
1-7, Chapter 1). Antigens such as animal dander, pollens, and dusts are the 1. Actual body weight should be used to calculate predicted values.
most common triggers. Other common triggers include exposure to air 2. Standing height should be measured when the patient is barefoot.
pollutants and exercise in cold or dry air. 3. Arm span should be used instead of height for a patient with kyphosis.
4. Age should be recorded to the nearest decade (10 years ).
DIF: 2 REF: p. 16 OBJ: EL-3 MSC: NBRC: None
a. 1 only
8. Which of the following statements concerning tumors in the upper airway is true?
b. 2 and 3
a. There may be variable or fixed obstruction.
c. 1 , 2, and 4
b. Fixed obstruction will be present.
d. 1 , 2, 3, and 4
c. Variable obstruction will be present.
d. Small airway obstruction will result. ANS: B
Various physical measurements are required for estimating each patient’s
ANS: A expected level of pulmonary function. Age to the nearest month, height to the
Tumors involving the upper airway may cause variable or fixed obstruction. nearest 0.1 cm, and weight are usually recorded in addition to the patient’s
gender. Race or ethnic origin should also be recorded. (Although body weight is
DIF: 2 REF: p. 19 OBJ: EL- recorded, it is not used to calculate predicted values.)
2 MSC: NBRC: CPFT 3C-3
DIF: 1 REF: p. 29 OBJ:
9. Sarcoidosis is a systemic disorder that usually causes which of the following? None MSC: NBRC: CPFT 3A-
a. A restrictive ventilatory defect 20
b. An obstructive ventilatory defect
c. Hyperreactive airways 12. In addition to explaining the procedure for each pulmonary function test to
d. Primary pulmonary hypertension the patient, the pulmonary function technologist should do which of the
following?
ANS: A a. Briefly explain the physiologic basis of the test.
Restriction is often associated with the following: interstitial lung diseases, b. Demonstrate the correct performance of the test maneuver.
including idiopathic fibrosis, pneumoconioses, and sarcoidosis. c. Limit feedback to the patient to reduce the placebo effect.
d. Explain the exact number of efforts that will be required for each test.
DIF: 1 REF: p. 19 | p. 21 OBJ: EL-3 MSC: NBRC: None
ANS: B
10. For which of the following conditions might pulmonary function testing be In addition to a description of the test, the maneuver should always be
contraindicated? demonstrated.
a. Vocal cord dysfunction
b. Untreated pneumothorax DIF: 1 REF: p. 32 OBJ:
c. Congestive heart failure (CHF) None MSC: NBRC: CPFT 2B-6
d. Bronchiolitis obliterans
13. The single-breath diffusing capacity test was first described by:
ANS: B
a. John Severinghaus
Pulmonary function tests are usually contraindicated in the presence of
b. August and Marie Krogh
pneumothorax. However, undiagnosed pneumothorax may present a risk if
pulmonary function studies are performed. c. Robert Hyatt
d. Leland Clark
DIF: 1 REF: p. 23 OBJ: EL- ANS: B
4 MSC: NBRC: CPFT 2B-6 The basis for the modern single-breath diffusing capacity (DLCO) test was
d. described by August and Marie Krogh in 1911.
DIF: 1 REF: p. 5 OBJ: None MSC: NBRC: None
|
, Stuvia.com - The Marketplace to Buy and Sell your Study Material Stuvia.com - The Marketplace to Buy and Sell your Study Material
14. DLCO measurements may be indicated to evaluate gas exchange abnormality Downloaded by: SuperA |
in which of the following?
Distribution of this document is illegal
a. Ketoacidosis
b. Myasthenia gravis
c. Interstitial lung disease
d. Bronchitis
ANS: C
The other options do not affect the alveolar capillary membrane
interface. DIF: 1 REF: p. 9 OBJ: EL-2 MSC:
NBRC: None
15. Vocal cord dysfunction will typically affect the flow-volume loop in what way?
a. Blunt the expiratory portion of the curve
b. Blunt both the inspiratory and expiratory portions of the curve
c. Blunt the inspiratory portion of the curve
Have no effect on the curve but cause inspiratory stridor
d.
